Accueil  >  

Tag: Réduction des méfaits

 

Meeting people where they are is about much more than location: Delivering hepatitis C care and treatment to people who use drugs

 14 octobre 2019 •  Par Tracy Swan

Poverty, stigma and criminalization are chronic problems among people who use and inject drugs. But hepatitis C virus (HCV) is no longer such a problem, since it is usually cured by eight to 12 weeks of oral, direct-acting antivirals (DAAs). Delivering DAAs to people who use and inject drugs in the context of the chronic problems facing them is an opportunity to recognize and support the contribution of people with lived experience, and to build and strengthen systems and programs. These systems and programs must provide welcoming, respectful and safe spaces for people who use and inject drugs, as they...

Pour en savoir plus...
 

Modèle directeur pour guider les efforts d’élimination de l’hépatite C au Canada : Une approche basée sur les populations prioritaires et l’équité en matière de santé – Deuxième partie

 29 août 2019 •  Par Jennifer Broad, Sandra Ka Hon Chu, Lindsay Jennings

Ce billet de blogue est un suivi d’un autre billet qui a été publié le 27 août, 2019 sur le Modèle directeur pour guider les efforts d’élimination de l’hépatite C au Canada. 

Pour en savoir plus...
 

Can Halifax open Atlantic Canada’s first legal overdose prevention site? Yes, we can!

 14 août 2019 •  Par Matthew Bonn

This blog post is a follow-up from an earlier post published on July 11, 2019. As I work on a new funding proposal, this statement strikes me: over 11,500 people in Canada have lost their lives as a result of opioid-related overdoses between January 2016 and December 2018 and we keep losing people every day. So many lives lost! And why is that? The evidence is clear that overdose prevention sites save lives! After I returned from a hands-on training in the Downtown East Side of Vancouver, one of the hardest hit places in the overdose crisis, it became even...

Pour en savoir plus...
 

L’hépatite C : Y aura-t-il 40 ans entre sa découverte et son élimination?

 3 juillet 2019 •  Par Melisa Dickie

Nous sommes au cœur d’une période incroyablement dynamique dans le monde de la médecine et de la santé publique. La recherche dans le domaine de l’hépatite C a progressé si rapidement que le virus pourrait être éliminé comme menace pour la santé publique seulement 40 ans après sa découverte en 1989.

Pour en savoir plus...
 

In the eyes of Indigenous people: The link between colonialism and hepatitis C, and the need for historic trauma-informed care

 15 avril 2019 •  Par Sadeem Fayed and Dr. Alexandra King

Why do First Nations, Métis and Inuit in Canada carry such an unfair burden of hepatitis C in Canada? It is estimated that hepatitis C among Indigenous people is five-times higher than non-Indigenous Canadians. In particular, Indigenous women represent almost half of all hepatitis C cases in their communities, a much higher proportion than among the non-Indigenous Canadian population. Young Indigenous people (24 years and under) represent 70% to 80% of hepatitis C infections among people who inject drugs in Canada.

Pour en savoir plus...